Paydirt
SO
Insider

Stephen Duane Oetgen

Director

Stephen Duane Oetgen (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in ARXS. Across 1 priced purchase filing, the average 21-session return was -8.2% from execution and -10.4% from disclosure (delay-adjusted; derived). The largest single filing was $700K of ARXS (25,000 sh × $28.00, as filed), executed Apr 17.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
-8.2%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-10.4%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$700K
shares × price, as filed
Last traded
Apr 17
Filed Apr 20
Open performance→
Volume by month
$700K$350K$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · buys $700K
Buys $700K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names
ARXS ARXS ARXS · 1 buy · 0 sells 1 filing
Recent filings
ARXSPURCHASE Arxis, Inc. View filing → $700K
25,000 sh × $28.00
Exec Apr 17
Filed Apr 20 · 9:07 PM ET